Table 2.
Study characteristics and quality assessment
| Study | Type of surgery | Study design | Patients in study/control groups, n | Consecutive series of patients | Length of follow-up | Age, years, median (range) | MINORS score | |
|---|---|---|---|---|---|---|---|---|
| ERAS group | Control group | |||||||
| van Dam et al. 200816 | HE, EHE, ME, SE, CR, RHE | Case–control | 61/100 | Yes | 30 days | 62 (24–82) | 60 (20–81) | 18/24 |
| Lin et al. 201122 | SE, HE, EHE, CR | Case–control | 56/61 | Yes | 30 days | 57 (23–73) | 55 (22–81) | 17/24 |
| Stoot et al. 200923 | Laparoscopic: ME, SE, LLS | Case–control | 13/13 | Yes | 3–6 months | 55 (34–82) | 45 (26–70) | 19/24 |
| Hendry et al. 201020 | HE, ME, SE, CR | RCT | 68a | Yes | 30 days | 62 (53–69) | – | 13/16 |
| Koea et al. 200921 | HE, EHE, ME, SE | RCT | 100a | Yes | 30 days | 60 (23–83) | – | 11/16 |
| MacKay & O'Dwyer 200824 | HE, SE | Retrospective case series | 12 | Yes | Unknown | 60 (43–74) | – | 8/16 |
a
Patients in the control and experimental arms were all treated according to ERAS protocols.
ERAS, enhanced recovery after surgery; HE, hemi-hepatectomy; EHE, extended hemi-hepatectomy; ME, metastasectomy; SE, segmentectomy; CR, central resection; RHE, repeat hemi-hepatectomy; LLS, left lateral sectionectomy; RCT, randomized controlled trial.